Diagnosis of chronic pancreatitis by using apparent diffusion coefficient measurements at 3.0-T MR following secretin stimulation

Radiology

Volumn 252, Issue 2, 2009, Pages 418-425

  Akisik, M Fatih ^a,b   Sandrasegaran, Kumaresan ^a,b   Jennings, S Gregory ^a,b   Aisen, Alex M ^a,b   Lin, Chen ^a,b   Sherman, Stuart ^a,b   Rydberg, Magnus P ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SECRETIN; CONTRAST MEDIUM; DIAGNOSTIC AGENT;

ADULT; ARTICLE; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; DISEASE SEVERITY; DRUG FORMULATION; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FEMALE; HUMAN; MAGNETIC RESONANCE CHOLANGIOPANCREATOGRAPHY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; COMPUTER ASSISTED DIAGNOSIS; IMAGE ENHANCEMENT; METHODOLOGY; MIDDLE AGED; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ADULT; CHOLANGIOPANCREATOGRAPHY, MAGNETIC RESONANCE; CONTRAST MEDIA; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; PANCREATITIS, CHRONIC; REPRODUCIBILITY OF RESULTS; SECRETIN; SENSITIVITY AND SPECIFICITY;

EID: 70249106751     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.2522081656     Document Type: Article

References (30)

1. Go VLM, Everhart JE. Pancreatitis. In: Everhart JE, ed. Digestive disease in the United States; epidemiology and impact. Washington, DC: U.S. Government Printing Office, 1994; 691-712.
2. Monill J, Pernas J, Clavero J, et al. Pancreatic duct after pancreatoduodenectomy: morphologic and functional evaluation with secretin-stimulated MR pancreatography. AJR Am J Roentgenol 2004;183:1267-1274. (Pubitemid 44210588)
3. Cappeliez O, Delhaye M, Devière J, et al. Chronic pancreatitis: evaluation of pancreatic exocrine function with MR pancreatography after secretin stimulation. Radiology 2000;215:358-364. (Pubitemid 30237828)
4. Fukukura Y, Fujiyoshi F, Sasaki M, Nakajo M. Pancreatic duct: morphologic evaluation with MR cholangiopancreatography after secretin stimulation. Radiology 2002;222:674-680. (Pubitemid 34215212)
5. Taouli B, Tolia AJ, Losada M, et al. Diffusion-weighted MRI for quantification of liver fibrosis: preliminary experience. AJR Am J Roentgenol 2007;189:799-806. (Pubitemid 47479760)
6. Hayakawa T, Kondo T, Shibata T, Noda A, Suzuki T, Nakano S. Relationship between pancreatic exocrine function and histological changes in chronic pancreatitis. Am J Gastroenterol 1992;87:1170-1174.
7. Sarles H, Bernard JP, Gullo L. Pathogenesis of chronic pancreatitis. Gut 1990;31:629-632.
8. Akisik FM, Sandrasegaran K, Aisen AM, Lin C, Lall C. Abdominal MR imaging at 3.0 T. RadioGraphics 2007;27:1433-1444.
9. Axon AT, Classen M, Cotton PB, Cremer M, Freeny PC, Lees WR. Pancreaticography in chronic pancreatitis: international definitions. Gut 1984;25:1107-1112. (Pubitemid 14002128)
10. Manfredi R, Costamagna G, Brizi MG, et al. Severe chronic pancreatitis versus suspected pancreatic disease: dynamic MR cholangiopancreatography after secretin stimulation. Radiology 2000;214:849-855. (Pubitemid 30115391)
11. Matos C, Metens T, Devière J, et al. Pancreatic duct: morphological and functional evaluation with dynamic MR pancreatography after secretin stimulation. Radiology 1997;203:435-441. (Pubitemid 27176218)
12. Hellerhoff KJ, Helmberger H, Rosch T, Settles MR, Link TM, Rummeny EJ. Dynamic MR pancreatography after secretin administration: image quality and diagnostic accuracy. AJR Am J Roentgenol 2002;179:121-129. (Pubitemid 34694824)
13. Erturk SM, Ichikawa T, Motosugi U, Sou H, Araki T. Diffusion-weighted MR imaging in the evaluation of pancreatic exocrine function before and after secretin stimulation. Am J Gastroenterol 2006;101:133-136. (Pubitemid 43381720)
14. Bali MA, Sztantics A, Metens T, et al. Quantification of pancreatic exocrine function with secretin-enhanced magnetic resonance cholangiopancreatography: normal values and short-term effects of pancreatic duct drainage procedures in chronic pancreatitis - initial results. Eur Radiol 2005;15:2110-2121. (Pubitemid 41403509)
15. Heverhagen JT, Müller D, Battmann A, et al. MR hydrometry to assess exocrine function of the pancreas: initial results of noninvasive quantification of secretin. Radiology 2001;218:61-67. (Pubitemid 32151273)
16. Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR Am J Roentgenol 2007;188:1622-1635. (Pubitemid 46866868)
17. Young GS. Advanced MRI of adult brain tumors. Neurol Clin 2007;25:947-973. (Pubitemid 47600577)
18. Schaefer PW, Grant PE, Gonzalez RG. Diffusion-weighted MR imaging of the brain. Radiology 2000;217:331-345.
19. Koh DM, Takahara T, Imai Y, Collins DJ. Practical aspects of assessing tumors using clinical diffusion-weighted imaging in the body. Magn Reson Med Sci 2007;6:211-224.
20. Naganawa S, Kawai H, Fukatsu H, et al. Diffusion-weighted imaging of the liver: technical challenges and prospects for the future. Magn Reson Med Sci 2005;4:175-186.
21. Matsuki M, Inada Y, Nakai G, et al. Diffusion-weighed MR imaging of pancreatic carcinoma. Abdom Imaging 2007;32:481-483.
22. Akisik MF, Aisen AM, Sandrasegaran K, et al. Assessment of chronic pancreatitis: utility of diffusion-weighted MR imaging with secretin enhancement. Radiology 2009;250:103-109.
23. Schmidt GP, Wintersperger B, Graser A, Baur-Melnyk A, Reiser MF, Schoenberg SO. High-resolution whole-body magnetic resonance imaging applications at 1.5 and 3 Tesla: a comparative study. Invest Radiol 2007;42:449-459. (Pubitemid 46788746)
24. Chow LC, Bammer R, Moseley ME, Sommer FG. Single breath-hold diffusion-weighted imaging of the abdomen. J Magn Reson Imaging 2003;18:377-382. (Pubitemid 37046523)
25. Merkle EM, Dale BM, Paulson EK. Abdominal MR imaging at 3T. Magn Reson Imaging Clin N Am 2006;14:17-26.
26. Mürtz P, Krautmacher C, Träber F, Gieseke J, Schild HH, Willinek WA. Diffusion-weighted whole-body MR imaging with background body signal suppression: a feasibility study at 3.0 Tesla. Eur Radiol 2007;17:3031-3037. (Pubitemid 350142327)
27. Kosior RK, Wright CJ, Kosior JC, et al. 3-Tesla versus 1.5-Tesla magnetic resonance diffusion and perfusion imaging in hyperacute ischemic stroke. Cerebrovasc Dis 2007;24:361-368.
28. Ding XQ, Wittkugel O, Goebell E, et al. Clinical applications of quantitative T2 determination: a complementary MRI tool for routine diagnosis of suspected myelination disorders. Eur J Paediatr Neurol 2008;12:298-308. (Pubitemid 351680714)
29. Habermann CR, Gossrau P, Kooijman H, et al. Monitoring of gustatory stimulation of salivary glands by diffusion-weighted MR imaging: comparison of 1.5T and 3T. AJNR Am J Neuroradiol 2007;28:1547-1551. (Pubitemid 47462945)
30. Guilfoyle DN, Suckow RF, Baslow MH. The apparent dependence of the diffusion coefficient of -acetylaspartate upon magnetic field strength: evidence of an interaction with NMR methodology. NMR Biomed 2003;16:468-474.